Immunocore Holdings PLC
NASDAQ:IMCR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
28.14
75.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Immunocore Holdings PLC
Wall Street
Price Targets
IMCR Price Targets Summary
Immunocore Holdings PLC
According to Wall Street analysts, the average 1-year price target for
IMCR
is 66.44 USD
with a low forecast of 24.24 USD and a high forecast of 105 USD.
IMCR Last Price Targets
Immunocore Holdings PLC
The latest public price target was made on Oct 24, 2024 by
David Dai
from
UBS
,
who expects
IMCR
stock to
drop by 15%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David Dai
UBS
|
24
USD
Downside 15% |
2 months ago
Oct 24, 2024
|
UBS Starts Immunocore Holdings (IMCR) at Sell
StreetInsider
|
Justin Kim
Oppenheimer
|
89
USD
Upside 216% |
3 months ago
Sep 16, 2024
|
Oppenheimer Reiterates Outperform Rating on Immunocore Holdings (IMCR)
StreetInsider
|
Graig Suvannavejh
Mizuho Securities
|
72
USD
Upside 156% |
3 months ago
Sep 12, 2024
|
Mizuho Reiterates Outperform Rating on Immunocore Holdings (IMCR)
StreetInsider
|
|
Patrick Trucchio
H.C. Wainwright
|
100
USD
Upside 255% |
3 months ago
Aug 28, 2024
|
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
StreetInsider
|
Peter Lawson
Barclays
|
66
USD
Upside 135% |
4 months ago
Aug 9, 2024
|
Immunocore price target lowered to $66 from $92 at Barclays
TheFly
|
|
Graig Suvannavejh
Mizuho Securities
|
88
USD
Upside 213% |
7 months ago
May 13, 2024
|
Immunocore Holdings (IMCR) PT Lowered to $88 at Mizuho
StreetInsider
|
Bill Maughan
Canaccord Genuity
|
67
USD
Upside 138% |
7 months ago
May 9, 2024
|
Immunocore Holdings (IMCR) PT Raised to $67 at Canaccord Genuity
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IMCR's stock price target?
Price Target
66.44
USD
According to Wall Street analysts, the average 1-year price target for
IMCR
is 66.44 USD
with a low forecast of 24.24 USD and a high forecast of 105 USD.
What is Immunocore Holdings PLC's Revenue forecast?
Projected CAGR
15%
For the last 4 years the
compound annual growth rate for
Immunocore Holdings PLC's revenue is
77%.
The projected
CAGR
for the next 4 years is
15%.
You don't have any saved screeners yet
